The coronavirus pandemic has highlighted how vulnerable global supply chains are, particularly in the area of pharmaceutical supply. Shortages of COVID-19 vaccines revealed how dependent Germany is on other countries. At the same time, it became clear how much potential for innovation there is in the German pharmaceutical industry. Since then, politicians and associations have been calling for a strategic realignment: the final synthesis steps for systemically important drugs should once again take place in Europe – with sustainability and efficiency in mind. In the »Smart-Form« project, we are supporting this goal by using artificial intelligence to develop a platform for optimizing and predicting formulation processes for nanotherapeutics.